Atea Pharmaceuticals
AVIR
AVIR
104 hedge funds and large institutions have $188M invested in Atea Pharmaceuticals in 2024 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 36 increasing their positions, 37 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
15% less capital invested
Capital invested by funds: $220M → $188M (-$32M)
38% less first-time investments, than exits
New positions opened: 13 | Existing positions closed: 21
94% less call options, than puts
Call options by funds: $297K | Put options by funds: $5.37M
Holders
104
Holding in Top 10
1
Calls
$297K
Puts
$5.37M
Top Buyers
| 1 | +$4.27M | |
| 2 | +$2.78M | |
| 3 | +$2.17M | |
| 4 |
TCM
Tang Capital Management
San Diego,
California
|
+$1.32M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$1.09M |
Top Sellers
| 1 | -$2.33M | |
| 2 | -$860K | |
| 3 | -$406K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$390K |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$358K |